<DOC>
	<DOCNO>NCT02196714</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Single-Dose , Four-Period , Four-Treatment , Cross-Over , Single-Center , Phase I , Crossover Study Healthy Japanese Adult Subjects Evaluate Safety Pharmacokinetics Two Doses PT003 Two Doses PT001 .</brief_summary>
	<brief_title>PK Study PT003 PT001 Japanese Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Informed Consent Form ( ICF ) prior study related procedure Male female first generation Japanese subject 18 45 year , inclusive Good general health Medically acceptable contraception woman childbearing potential male female partner childbearing potential Clinical lab within normal range determine clinically significant Investigator Pregnancy , nurse female subject , subject try conceive Clinically significant neurologic , cardiovascular , hepatic , renal , endocrinologic , pulmonary , hematological , psychiatric , medical illness would interfere participation study History ECG abnormalities Cancer complete remission least 5 year Clinically significant , symptomatic prostatic hypertrophy Male subject transurethral resection prostate full resection prostate within 6 month prior Screening Clinically significant bladder neck obstruction urinary retention Inadequately treat glaucoma History allergic reaction hypersensitivity drug component formulation use study Subjects preexist anemia and/or iron deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Japanese Healthy Volunteers</keyword>
</DOC>